U.S. stocks opened, with the Dow Jones Industrial Average down 0.07%, the S&P 500 Index up 0.03%, and the Nasdaq Composite Index up 0.15%. Novo Nordisk (NVO.N) rose 10.62% after clinical trials showed that its weight loss drug Amycretin can reduce weight by 22%. Meta Platforms (META.O) fell 0.19%, CEO Zuckerberg plans to significantly expand the artificial intelligence team. Nvidia (NVDA.O) rose 1%.

2025-01-24 22:31:10

Nvidia weight loss drug AI Novo Nordisk Meta

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Southwest Airlines CEO: Although Boeing still has a lot of work to do, they seem to be moving in a good direction and we are more optimistic.
                            2025-01-31

                                    White House Press Secretary Levitt: Details about the Nvidia meeting are still unclear.
                            2025-02-01

                                    Apple (AAPL.O) said the Apple Pay outage has been resolved.
                            2025-01-29

                                    Jefferies: Raised Meta Platforms (META.O) price target from $715 to $810.
                            2025-01-30

                                    Sam Altman, founder and CEO of OpenAI: OpenAI will develop specialized hardware for AI.
                            2025-02-03